Table 8.
Occurrence of high‐level resistance to ciprofloxacin (MIC ≥ 4 mg/L) in Salmonella serovars isolated from humans in 2017, 5 MSs
| Serovar | N | High‐level resistance to ciprofloxacin(MIC ≥ 4 mg/L) | |
|---|---|---|---|
| n | % | ||
| S. Agona | 56 | 1 | 1.8 |
| S. Brandenburg | 66 | 1 | 1.5 |
| S. Derby | 89 | 1 | 1.1 |
| S. Dublin | 59 | 2 | 3.4 |
| S. Enteritidis | 866 | 4 | 0.5 |
| S. Infantis | 126 | 2 | 1.6 |
| S. Kentucky | 68 | 63 | 92.6 |
| Monophasic S. Typhimurium | 861 | 6 | 0.7 |
| S. Newport | 77 | 2 | 2.6 |
| S. Saintpaul | 26 | 1 | 3.8 |
| S. Typhimurium | 756 | 4 | 0.5 |
| Other | 897 | 0 | 0.0 |
| Total (5 MSs) | 3,947 | 87 | 2.2 |
MIC: minimum inhibitory concentration; MS: Member State.